1981 completed, 510 terminated, 293 active not recruiting, 176 withdrawn. 1446 Phase 2, 999 Phase 1, 255 Not applicable, 168 Phase 3, 59 Early Phase 1.
Follow Laboratory Biomarker Analysis: new trials by email Literature Review of Laboratory Biomarker Analysis trials Research Report on Laboratory Biomarker Analysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men Cytology Specimen Collection Procedure, High Resolution Anoscopy with Biopsy, Laboratory Biomarker Analysis - HIV Infection, Human Papillomavirus Infection | Withdrawn | AIDS Malignancy Consortium | 2027-04-30 | 2025-06-06 | ||
| Incidence of HIV Infection in Screening Indian Men Who Have Sex With Men Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Medical Examination - HIV Infection | Withdrawn | AIDS Malignancy Consortium | 2027-04-30 | 2025-06-06 | ||
| Clinical Applicability of Liquid Biopsy in Chondrosarcoma laboratory biomarker analysis, Molecular pathology - Chondrosarcoma of the Bone | Recruiting | Medical University of Graz | 60 | 2026-06-01 | 2026-10-07 | |
| The Association Between Postoperative Inflammatory and Neurological Serum Biomarker Concentrations and Occurrence of Postoperative Delirium laboratory biomarker analysis, 3D-CAM/CAM-ICU - Delirium - Postoperative, Neuronal Damage | Recruiting | Medical University of Vienna | 1170 | 2026-01-12 | 2026-02-17 | |
| Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course and Prognosis Echocardiography, Spirometry, Body plethysmography - COPD (Chronic Obstructive Pulmonary Disease), Heart Failure With Preserved Ejection Fraction (HFpEF; Diagnosis) | Recruiting | National Medical Research Center for Therapy and Preventive Medicine | 200 | 2026-01-01 | 2026-02-10 | |
| Predictive Model for Mortality in Older People With Critical Illness laboratory biomarker analysis - Critical Illness | Recruiting | Consorci Sanitari de l'Alt Penedès i Garraf | 450 | 2025-03-20 | 2025-12-02 | |
| Demographic and Interpopulation Variations in Evaluation and Results of TAVI laboratory biomarker analysis, Computed tomography of aortic root and aorta - Aortic Stenosis, TAVI(Transcatheter Aortic Valve Implantation) | Enrolling by invitation | Poznan University of Medical Sciences | 800 | 2025-01-01 | 2025-12-02 | |
| An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer Alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside, Computed Tomography, Laboratory Biomarker Analysis - Lung Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 60 | 2023-01-19 | 2025-11-10 |
| Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome Navitoclax, Venetoclax, Decitabine - Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome | Phase 1 | Completed | Thomas Jefferson University | 6 | 2023-01-12 | 2026-05-19 |
| Entrectinib in Combination With ASTX727 for the Treatment of Relapsed/Refractory TP53 Mutated Acute Myeloid Leukemia Decitabine and Cedazuridine, Entrectinib, Laboratory Biomarker Analysis - Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia | Phase 1 | Active not recruiting | OHSU Knight Cancer Institute | 13 | 2022-10-28 | 2026-10-15 |
| Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases Laboratory Biomarker Analysis, Neurocognitive Assessment, Questionnaire Administration - Brain Metastases, Adult | Not applicable | Suspended | Ohio State University Comprehensive Cancer Center | 24 | 2022-09-26 | 2026-02-10 |
| Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer therapeutic conventional surgery, laboratory biomarker analysis, quality-of-life assessment - Oropharynx Cancer | Phase 2 | Recruiting | Heath Skinner | 150 | 2022-07-20 | 2026-07-21 |
| Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer Best Practice, Biopsy, Biospecimen Collection - Advanced Breast Adenocarcinoma, Advanced HER2-Negative Breast Carcinoma | Not applicable | Withdrawn | City of Hope Medical Center | 2022-07-03 | 2022-06-09 | |
| Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes Dilanubicel, Cyclophosphamide, Fludarabine - Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Active not recruiting | Fred Hutchinson Cancer Center | 31 | 2022-05-10 | 2026-07-10 |
| Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant Laboratory Biomarker Analysis, Lenvatinib - Recurrent Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8 | Phase 2 | Terminated | Emory University | 3 | 2022-04-19 | 2026-04-24 |
| Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures Best Practice, Laboratory Biomarker Analysis, Oculus Rift Headset - Malignant Neoplasm | Not applicable | Suspended | University of Southern California | 60 | 2022-03-01 | 2026-05-13 |
| 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant Fluorine F 18 L-glutamate Derivative 18F-FSPG, Carbon C 11 Acetate, Positron Emission Tomography - Adult Hepatocellular Carcinoma, Resectable Hepatocellular Carcinoma | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 110 | 2022-02-15 | 2026-06-02 |
| Genetic Overlap Between Anomalies and Cancer in Kids in the Children's Oncology Group: The COG GOBACK Study Whole Genome Sequencing, Questionnaire Administration, Biospecimen collection - Congenital Anomaly, Pediatric Cancer | Active not recruiting | Children's Oncology Group | 1000 | 2021-09-10 | 2026-02-06 | |
| Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix Electronic Health Record Review, Laboratory Biomarker Analysis - Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type | Recruiting | M.D. Anderson Cancer Center | 70 | 2021-08-06 | 2026-08-10 | |
| Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy F-18 16 Alpha-Fluoroestradiol, Positron Emission Tomography, Computed Tomography - Estrogen Receptor Positive, Primary or Recurrent Breast Carcinoma | Phase 2 | Active not recruiting | University of Washington | 2 | 2021-07-10 | 2026-07-01 |
Showing 20 of 3156. Sign in to see all of them.
Breast Neoplasms (371) · Leukemia, Myeloid, Acute (228) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (197) · Prostatic Neoplasms (186) · Carcinoma, Non-Small-Cell Lung (174) · Leukemia, Lymphocytic, Chronic, B-Cell (169) · Multiple Myeloma (147) · Lymphoma, Follicular (140) · Lymphoma, Large B-Cell, Diffuse (139) · Melanoma (131) · Lymphoma, Mantle-Cell (129) · Lymphoma, Non-Hodgkin (128) · Burkitt Lymphoma (117) · Ovarian Neoplasms (117) · Congenital Abnormalities (116)
National Cancer Institute (NCI) (999) · Children's Oncology Group (189) · M.D. Anderson Cancer Center (177) · City of Hope Medical Center (142) · Mayo Clinic (136) · Fred Hutchinson Cancer Center (105) · Roswell Park Cancer Institute (94) · University of Washington (88) · University of Southern California (74) · Vanderbilt-Ingram Cancer Center (61) · Wake Forest University Health Sciences (57) · SWOG Cancer Research Network (48) · Jonsson Comprehensive Cancer Center (45) · Ohio State University Comprehensive Cancer Center (44) · Northwestern University (42)
United States (2693) · Canada (217) · Puerto Rico (86) · United Kingdom (82) · Australia (69) · France (40) · New Zealand (37) · Switzerland (30) · Italy (23) · South Korea (17) · Netherlands (16) · Ireland (15) · Belgium (13) · Germany (12) · Japan (12)
Alex Adjei (12) · Brenda Sandmaier (11) · Vassiliki Papadimitrakopoulou (11) · David Maloney (10) · Ajay Gopal (8) · Hannah Linden (8) · Hedy Kindler (8) · Shaji Kumar (8) · Kunle Odunsi (7) · Paul Pharoah, MD (7) · Seth Pollack (7) · A. Bapsi Chakravarthy, MD (6) · Aminah Jatoi, M.D. (6) · Amit Oza (6) · Heinz-Josef Lenz (6)
PMID 32499241, PMID 31401903, PMID 37185961, PMID 24383844, PMID 25527568, PMID 31171508, PMID 34515338, PMID 34616010, PMID 36184192, PMID 41671463, PMID 29618479, PMID 32379297, PMID 32632956, PMID 34162404, PMID 35254001, PMID 35622074, PMID 38603649, PMID 14520092, PMID 21997132, PMID 23660685, PMID 24583822, PMID 25057165, PMID 26586415, PMID 26943915, PMID 27118452, PMID 28419486, PMID 30573690, PMID 31375469, PMID 31375516, PMID 32269142, PMID 32827353, PMID 33277073, PMID 33439748, PMID 34028627, PMID 34548240, PMID 34608724, PMID 34797699, PMID 35007144, PMID 35135810, PMID 35787017, PMID 36351402, PMID 36648215, PMID 37146227, PMID 37890117, PMID 38396300, PMID 38741776, PMID 39121442, PMID 39321347, PMID 39558017, PMID 40132910
P30CA015704 (127), P30CA015083 (106), U10CA098543 (77), U10CA027469 (75), P30CA016672 (73), U10CA180868 (72), U10CA031946 (68), U10CA032102 (61), P30CA014089 (58), P30CA033572 (55), U10CA180821 (54), U10CA021115 (48), U10CA180886 (47), P30CA068485 (42), P30CA060553 (40)